中国血液净化

中国血液净化 ›› 2019, Vol. 18 ›› Issue (10): 661-663.doi: 10.3969/j.issn.1671-4091.2019.10.001

• 卫生健康事业发展70年巡礼●专栏 •    下一篇

中国腹膜透析发展70年

倪兆慧1,金海姣1   

  1. 1. 上海交通大学医学院附属仁济医院肾脏科
  • 收稿日期:2019-08-12 修回日期:2019-08-18 出版日期:2019-10-12 发布日期:2019-09-27
  • 通讯作者: 倪兆慧 profnizh@126.com E-mail:profnizh@126.com

The developmental history of peritoneal dialysis in China in the 70 years

  1. 1Department of Nephrology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China
  • Received:2019-08-12 Revised:2019-08-18 Online:2019-10-12 Published:2019-09-27

PDF

2398

摘要： 【摘要】我国尿毒症患者约100～200 万人，给社会带来了巨大的医疗资源和经济负担。腹膜透析具有简单便捷、安全有效、居家治疗的优势，已成为我国尿毒症患者适宜的替代治疗方式之一。从1999年的全国腹膜透析患者4380 例，至2018 年底登记存活腹膜透析患者86 264 例，我国腹膜透析患者人数增长近20 倍。随着透析登记系统的完善、腹膜透析标准操作规程的推广、腹膜透析高质量临床研究的推进，腹膜透析质量不断改善，中国的腹膜透析多年的实践积累了丰富的治疗和管理经验，在国际上建立了良好的声誉。

关键词: 腹膜透析, 终末期肾病, 发展史

Abstract:

【Abstract】There are about 1,000,000～2,000,000 patients with end-stage renal disease (ESRD) in China, which consumes huge medical resources and results in great economic burden to the society. Peritoneal dialysis (PD) has the advantages of convenience, safe, effective and home treatment, becoming one of the alternative treatment methods suitable for ESRD patients in China. The number of registered PD patients increases nearly 20 times from 4,380 in 1999 to 86,264 by the end of 2018. With the improvement of dialysis registration system, the widespread utilization of standard PD operating protocols, and the increase of high- quality clinical studies on PD in China, we have achieved continuous advances in PD quality, large experiences in treatment and management of PD, and excellent reputations about the treatment of PD in the international community.

Key words: Peritoneal dialysis, End-stage renal disease, Development history

中图分类号: